Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.330
-0.020 (-1.48%)
Oct 2, 2026, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
---4.64.141.09
Revenue Growth
---11.18%279.61%-
Gross Profit
---1.11.40.54
Operating Income
-9.9-9.9-8.45-8.13-8.38-13.59
Net Income
-12.99-12.99-8.16-7.68-7.95-18.6
Earnings Per Share
-3.12-3.12-8.36-20.14-64.92-663.32
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
2.232.2310.796.618.966.22
Total Debt
--0.740.960.390.79
Net Cash (Debt)
2.232.2310.055.658.575.43
Net Cash Growth
-77.76%-77.76%77.73%-34.01%57.80%-23.98%
Net Cash Per Share
0.540.5410.2914.8369.96193.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-8.64-8.64-8.1-6.99-7.28-15.58
Capital Expenditures
----0.01-0.16-0.04
Free Cash Flow
-8.64-8.64-8.1-7-7.45-15.62
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
---23.95%33.93%49.89%
Operating Margin
----176.92%-202.60%-1247.60%
Pretax Margin
----166.79%-191.86%-1707.32%
Profit Margin
----166.94%-192.18%-1707.32%
FCF Margin
----152.14%-180.02%-1434.03%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
---0.520.758.85